0000902664-22-005341.txt : 20221230
0000902664-22-005341.hdr.sgml : 20221230
20221230171635
ACCESSION NUMBER: 0000902664-22-005341
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221229
FILED AS OF DATE: 20221230
DATE AS OF CHANGE: 20221230
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Caligan Partners LP
CENTRAL INDEX KEY: 0001727492
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34180
FILM NUMBER: 221502621
BUSINESS ADDRESS:
STREET 1: 590 MADISON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 718-570-6018
MAIL ADDRESS:
STREET 1: 590 MADISON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: STANDARD BIOTOOLS INC.
CENTRAL INDEX KEY: 0001162194
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 770513190
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 TOWER PLACE
STREET 2: SUITE 2000
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6502666000
MAIL ADDRESS:
STREET 1: 2 TOWER PLACE
STREET 2: SUITE 2000
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: FLUIDIGM CORP
DATE OF NAME CHANGE: 20011113
4
1
ownership.xml
X0306
4
2022-12-29
0
0001162194
STANDARD BIOTOOLS INC.
LAB
0001727492
Caligan Partners LP
590 MADISON AVENUE
NEW YORK
NY
10022
0
0
1
0
Common Stock, $0.001 par value per share (Common Stock)
2022-12-29
4
J
0
2868037
D
8576799
I
See footnote
This transaction represents an in-kind distribution by certain funds and accounts to which Caligan Partners LP ("Caligan") serves as the investment manager.
The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.
The Reporting Persons disclaim beneficial ownership in the securities reported on this Form 4 except to the extent of his or its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that any of the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Caligan Partners LP, By: /s/ David Edward Johnson, Partner /s/ David Edward Johnson
2022-12-30